Mark E Nance Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark E Nance.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark E Nance. Mark E Nance is Chief Legal Officer & Gen Cnsl in Insys Therapeutics, Inc. ($INSY) and General Counsel in Envista Holdings Corp ($NVST) and Senior Vice President, GC, Sec in Envista Holdings Corp ($NVST).
Latest Insider Trading Transactions of Mark E Nance
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | NVST | Envista Holdings C ... | Nance Mark E | General Counsel | Option Exercise | A | 37.94 | 34,610 | 1,313,103 | 34,610 | |
| Feb 26 2021 | NVST | Envista Holdings C ... | Nance Mark E | General Counsel | Grant | A | 0.00 | 9,230 | 0 | 28,422 | 19.2 K to 28.4 K (+48.09 %) |
| Feb 26 2021 | NVST | Envista Holdings C ... | Nance Mark E | General Counsel | Payment of Exercise | F | 37.94 | 749 | 28,417 | 19,192 | 19.9 K to 19.2 K (-3.76 %) |
| Feb 17 2021 | NVST | Envista Holdings C ... | Nance Mark E | General Counsel | Option Exercise | A | 0.00 | 967 | 0 | 967 | |
| Jul 17 2020 | NVST | Envista Holdings C ... | Nance Mark E | SENIOR VICE PRESIDE ... | Payment of Exercise | F | 21.85 | 540 | 11,799 | 19,941 | 20.5 K to 19.9 K (-2.64 %) |
| Feb 26 2020 | NVST | Envista Holdings C ... | Nance Mark E | SENIOR VICE PRESIDE ... | Option Exercise | A | 26.50 | 41,790 | 1,107,435 | 41,790 | |
| Feb 26 2020 | NVST | Envista Holdings C ... | Nance Mark E | SENIOR VICE PRESIDE ... | Grant | A | 0.00 | 11,325 | 0 | 20,481 | 9.2 K to 20.5 K (+123.69 %) |
| Dec 20 2019 | NVST | Envista Holdings C ... | Nance Mark E | Senior Vice Preside ... | Option Exercise | A | 27.05 | 29,527 | 798,705 | 29,527 | |
| Dec 20 2019 | NVST | Envista Holdings C ... | Nance Mark E | Senior Vice Preside ... | Grant | A | 0.00 | 9,156 | 0 | 9,156 | 0 to 9.2 K |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 23 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 3.81 | 70,000 | 266,700 | 70,000 | |
| Apr 19 2019 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 10,000 | 0 | 25,000 | 15 K to 25 K (+66.67 %) |
| Oct 12 2018 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Option Exercise | A | 8.61 | 100,000 | 861,000 | 100,000 | |
| Oct 12 2018 | INSY | Insys Therapeutics ... | Nance Mark E | Chief Legal Officer ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Page: 1